Mirae Asset Global Investments Co., Ltd. Vir Biotechnology, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,340 shares of VIR stock, worth $30,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,340

Previous 4,536 17.72%

Holding current value

$30,972

Previous $29,000 10.34%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	BUY	$4.5 - $6.48 $3,618 - $5,209	804 Added 17.72%	5,340 $26,000
Q1 2025 Apr 24, 2025	SELL	$6.48 - $12.48 $343 - $661	-53 Reduced 1.15%	4,536 $29,000
Q4 2024 Jan 27, 2025	SELL	$6.74 - $10.17 $2,379 - $3,590	-353 Reduced 7.14%	4,589 $33,000
Q3 2024 Oct 23, 2024	BUY	$7.26 - $10.7 $6,388 - $9,416	880 Added 21.66%	4,942 $37,000
Q2 2024 Jul 30, 2024	SELL	$7.63 - $12.66 $346,882 - $575,561	-45,463 Reduced 91.8%	4,062 $36,000
Q1 2024 May 01, 2024	SELL	$8.6 - $11.9 $1.41 Million - $1.94 Million	-163,377 Reduced 76.74%	49,525 $501,000
Q4 2023 Jan 24, 2024	BUY	$7.76 - $10.29 $1.2 Million - $1.6 Million	155,196 Added 268.94%	212,902 $2.14 Million
Q3 2023 Oct 26, 2023	BUY	$9.14 - $24.62 $33,159 - $89,321	3,628 Added 6.71%	57,706 $540,000
Q2 2023 Aug 10, 2023	BUY	$23.2 - $27.29 $107,578 - $126,543	4,637 Added 9.38%	54,078 $1.33 Million
Q1 2023 May 04, 2023	BUY	$22.26 - $30.85 $232,372 - $322,043	10,439 Added 26.77%	49,441 $1.15 Million
Q4 2022 Feb 09, 2023	BUY	$19.96 - $28.22 $47,804 - $67,586	2,395 Added 6.54%	39,002 $987,000
Q3 2022 Nov 10, 2022	SELL	$18.26 - $31.1 $1.39 Million - $2.36 Million	-75,917 Reduced 67.47%	36,607 $706,000
Q2 2022 Jul 26, 2022	BUY	$19.08 - $26.7 $2.07 Million - $2.89 Million	108,255 Added 2535.84%	112,524 $8.21 Million
Q2 2021 Aug 11, 2021	BUY	$38.75 - $51.0 $165,423 - $217,719	4,269 New	4,269 $202,000

Others Institutions Holding VIR

# of Institutions

241

Shares Held

109M

Call Options Held

342K

Put Options Held

150K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $769M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Vir Biotechnology, Inc. Transaction History